Long-term outcomes and clinical worsening in cystic fibrosis patients with at least one residual function mutation
A. Gramegna (Milan, Italy), M. Contarini (Milan, Italy), S. Aliberti (Milan, Italy), G. Sotgiu (Sassari, Italy), M. Seia (Milan, Italy), L. Porcaro (Milan, Italy), A. Colombo (Milan, Italy), N. Vanoni (Milan, Italy), F. Amati (Milan, Italy), G. Pizzamiglio (Milan, Italy), M. Di Pasquale (Milan, Italy), S. Dellafiore (Milan, Italy), M. Pappalettera (Milan, Italy), C. Castellani (Verona, Italy), B. Assael (Milan, Italy), F. Blasi (Milan, Italy)
Source: International Congress 2018 – Cystic fibrosis in adults: current research
Session: Cystic fibrosis in adults: current research
Session type: Thematic Poster
Number: 1324
Disease area: Respiratory infections
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Gramegna (Milan, Italy), M. Contarini (Milan, Italy), S. Aliberti (Milan, Italy), G. Sotgiu (Sassari, Italy), M. Seia (Milan, Italy), L. Porcaro (Milan, Italy), A. Colombo (Milan, Italy), N. Vanoni (Milan, Italy), F. Amati (Milan, Italy), G. Pizzamiglio (Milan, Italy), M. Di Pasquale (Milan, Italy), S. Dellafiore (Milan, Italy), M. Pappalettera (Milan, Italy), C. Castellani (Verona, Italy), B. Assael (Milan, Italy), F. Blasi (Milan, Italy). Long-term outcomes and clinical worsening in cystic fibrosis patients with at least one residual function mutation. 1324
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Clinical characteristics and disease severity of adults with cystic fibrosis with at least one residual function mutation Source: International Congress 2018 – Cystic fibrosis in adults: current research Year: 2018
Impact of CFTR modulator use on outcomes in people with severe cystic fibrosis lung disease Source: Eur Respir Rev, 29 (155) 190112; 10.1183/16000617.0112-2019 Year: 2020
Do causes influence clinical, functional and quality of life aspects on patients with bronchiectasis not associated with cystic fibrosis? Source: International Congress 2019 – Chronic cough, a1-antitrypsin deficiency and other conditions Year: 2019
Long-term course of lung clearance index among patients with cystic fibrosis Source: Virtual Congress 2020 – Respiratory physiology and sleep: new approaches to diagnosis and treatment Year: 2020
Does lung transplantation affect on the improvement of psychological status in patients with adult cystic fibrosis? Source: International Congress 2018 – Contemporary respiratory care: symptoms, the role of the nurse and the organisation of care Year: 2018
One-year follow-up for lung function and functional capacity in cystic fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 183s Year: 2005
Doxycycline improves clinical outcomes during cystic fibrosis exacerbations Source: Eur Respir J , 49 (4) 1601102; DOI: 10.1183/13993003.01102-2016 Year: 2017
Clinical and functional determinants of exercise limitation in adult patients with cystic fibrosis Source: Annual Congress 2012 - Limiting factors in exercise Year: 2012
Survival and course of lung function in the presence or absence of antifibrotic treatment in patients with idiopathic pulmonary fibrosis: long-term results of the INSIGHTS-IPF registry Source: Eur Respir J, 56 (2) 1902279; 10.1183/13993003.02279-2019 Year: 2020
Real-world antifibrotic treatment persistence and clinical outcomes for patients with idiopathic pulmonary fibrosis Source: Virtual Congress 2021 – Interstitial lung disease around the world Year: 2021
Improvement in pulmonary function after IV antibiotic treatment in cystic fibrosis patients Source: Eur Respir J 2002; 20: Suppl. 38, 342s Year: 2002
Hyaluroman syntehase-2 over expression has impact in the evolution and on the prognosis of idiopathic pulmonary fibrosis patients Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis Year: 2012
Concomitant medications and clinical outcomes in idiopathic pulmonary fibrosis Source: Eur Respir J, 54 (6) 1901188; 10.1183/13993003.01188-2019 Year: 2019
Whether low frequency of hepatobiliary abnormalities in cystic fibrosis patients is associated with anti-inflammatory treatment? Source: Annual Congress 2008 - Cystic fibrosis: a disease with many aspects Year: 2008
Does splenectomy in cystic fibrosis related liver disease improve lung function and nutritional status? A case series Source: Eur Respir J 2006; 28: Suppl. 50, 263s Year: 2006
Factors affecting progression of lung disease among patients with cystic fibrosis Source: International Congress 2019 – Physiology of cystic fibrosis Year: 2019
Examining the effects of the Gly551Asp mutation on CT outcomes in children with cystic fibrosis Source: International Congress 2017 – Cystic fibrosis: treatments and monitoring Year: 2017
Can clinical data predict rapid decline of lung function in idiopathic pulmonary fibrosis (IPF) patients? Source: International Congress 2017 – IPF: from the bench to the bedside Year: 2017
Relationship between nutritional and clinical status in adult cystic fibrosis patients Source: Eur Respir J 2006; 28: Suppl. 50, 58s Year: 2006
Structural determinants of long-term functional outcomes in young children with cystic fibrosis Source: Eur Respir J, 55 (5) 1900748; 10.1183/13993003.00748-2019 Year: 2020